PROBLEM TO BE SOLVED: To provide a pharmaceutical composition comprising an interleukin-13(IL-13) antibody.SOLUTION: A pharmaceutical composition for treating IL-13 related disorders such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, chronic obstructive pulmonary disease, scleroderma, inflammatory bowel disease and Hodgkin's lymphoma, particularly asthma, comprises an IL-13 antibody purified in chromatographic separation step, more specifically a monoclonal IL-13 antibody and especially a human IL-13 monoclonal antibody. The IL-13 antibody is in the buffer state at pH 4.5 to 6.0 in an acetate buffer and contained in the pharmaceutical composition in an amount of 1 to 200 mg/ml, and the pharmaceutical composition comprises one or more kinds of pharmaceutically acceptable excipients.COPYRIGHT: (C)2014,JPO&INPIT【課題】インターロイキン－１３（ＩＬ－１３）抗体を含む、医薬組成物の提供。【解決手段】クロマトグラフ分離工程により、精製されたＩＬ－１３抗体、より特にモノクローナルＩＬ－１３抗体、とりわけヒトＩＬ－１３モノクローナル抗体を含む、喘息、アトピー性皮膚炎、アレルギー性鼻炎、線維症、慢性閉塞性肺疾患、強皮症、炎症性腸疾患およびホジキンリンパ腫、特に喘息のようなＩＬ－１３関連障害の処置を行うための医薬組成物。該ＩＬ－１３抗体は酢酸緩衝液でｐＨ４．５～６．０に緩衝状態であり、医薬組成物中に１～２００ｍｇ／ｍｌの量で含有し、一種以上の薬学的に許容された賦形剤を含む医薬組成物。【選択図】なし
